On July 23, 2008, Breast Cancer Research and Treatment journal released an electronic publication ahead of print of the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes [1]. The gene discussed is BRCA1; the disease is breast carcinoma.